For instance, plasma thymidine kinase 1 activity has been shown to be a clinically effective novel circulating prognostic marker in ER+/HER2− metastatic BC patients receiving ET and Palbociclib treatment.370 Additionally, synergistic effects between hormonal therapy and radiation therapy have been established in the oncology field. The gene discussed is ESR1; the disease is breast cancer.